This kidney researcher hopes to break a lethal chain of inheritance
Anna Greka has become a champion for patients with rare diseases, blurring the sharp lines that often lie between the lab and the real world.
Stay updated with breaking news from Anthony Bleyer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Anna Greka has become a champion for patients with rare diseases, blurring the sharp lines that often lie between the lab and the real world.
Gout treatment with pegloticase was well tolerated in a dialysis-dependent population, researchers found in a small study. In an analysis of 42 patients with uncontrolled gout currently undergoing routine outpatient dialysis, most received on-label pegloticase (Krystexxa) consisting of biweekly infusions, with a median of three infusions, reported Anthony Bleyer, MD, of Wake Forest School of Medicine in Winston-Salem, North Carolina, and colleagues. In total, nine patients (21%) received 12 or more pegloticase infusions, and the median interval between doses was 14 days (average of 19.5 days)...